2Department of Internal Medicine, Lokman Hekim University SUAM, Ankara, Türkiye
3Department of Gastroenterology, Gazi University Faculty of Medicine, Ankara, Türkiye
4Division of Gastroenterology, Department of Internal Medicine, Lokman Hekim University Faculty of Medicine, Ankara, Türkiye
Introduction: We aimed to compare the amylase levels in hospitalized patients for COVID-19 infection, who were discharged or expired, to investigate the relationship between amylase levels and outcomes of COVID-19 infection.
Methods: In all patients having the symptoms of COVID-19, the diagnosis was established by reverse transcriptase-polymerase chain reaction. Demographic features, complete medical history, and laboratory findings of the study participants at admission are obtained from the medical records.
Results: A total of 145 patients (51 females and 94 males) were included in the study. Although liver function tests and kidney function tests were significantly different between discharged and expired patients, there was no significant difference regarding the serum amylase levels at admission. In our laboratory, the upper limit of amylase level is 100 U/L. Regarding this upper limit, 72 patients (67.3%) in the discharged group and 30 patients (78.9%) in the expired group had hyperamylasemia. There was not any significant difference between the two groups, regarding the hyperamylasemia prevalence (p=0.32).
Discussion and Conclusion: In patients hospitalized for COVID-19 infection, there was not any significant difference regarding the serum amylase levels between discharged and expired patients. We believe that serum amylase levels at admission cannot be regarded as a prognostic factor in COVID-19 patients.
2Lokman Hekim Üniversitesi SUAM, İç Hastalıkları Anabilim Dalı, Ankara
3Gazi Üniversitesi Tıp Fakültesi, Gastroenteroloji Anabilim Dalı, Ankara
4Lokman Hekim Üniversitesi Tıp Fakültesi, İç Hastalıkları Anabilim Dalı, Gastroenteroloji Anabilim Dalı, Ankara